Expert Consultations: Real-World Answers

Obsessive-Compulsive and Related Disorders – Interview

Published on February 1, 2022 Expired on April 1, 2025

Guest

Wegdan Rashad

To unlock this audio you need to become a Silver, Gold, Silver extended or Gold extended Member.

Check Our CME Program

Downloads for Offline Access

Download Audio File (MP3)

Interview Highlights

Obsessive-compulsive and related disorders (OCRDs) are common disorders that may be overlooked by the general clinician.
An integrated approach to treatment, which includes psychotherapy and pharmacotherapy in the form of SSRIs and clomipramine, is recommended.

Text Version

This edition of Psychopharmacology Institute’s Expert Consultations features Robert Hudak, M.D., who is an associate professor of psychiatry at the University of Pittsburgh. He is also the Medical Director of the OCD Intensive Outpatient Program at Western Psychiatric Institute and Clinic. Dr. Hudak is also the editor of a book entitled Clinical Obsessive-Compulsive Disorders in Adults and Children by Cambridge University Press, and is the Course Director for the Obsessive-Compulsive and Related Disorders course at the University of Pittsburgh Office of Residency Training in the Department of Psychiatry. In this

Unlock this Expert Consultation and earn 0.50 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.

Get Instant Access

Already have an account? Sign in

Learning Objectives:

After completing this activity, the learner will be able to:

Discuss the prevalence and clinical features of obsessive-compulsive and related disorders.
Identify psychotherapeutic and pharmacologic strategies for the management of these disorders.

Original Release Date: 02/01/2022

Review and Re-release Date: 03/01/2024

Expiration Date: 04/01/2025

Expert: Robert Hudak, M.D.

Medical Editors: Wegdan Rashad, M.D., Melissa Mariano, M.D.

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationship(s) to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Answer the quiz for promoting retention of knowledge.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Robert Hudak, M.D.